Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Seratrodast is a selective CysLT2 receptor antagonist developed for respiratory disorders. Its molecular formula is C21H27N5O4 with CAS No. 196807-54-2. The core synthesis involves advanced heterocyclic coupling.
Application
- Asthma management targeting leukotriene-mediated inflammation.
- Allergic rhinitis treatment reducing nasal congestion.
- Chronic obstructive pulmonary disease (COPD) symptom control.
Precautions
Strictly adhere to clinical dosage limits to avoid hepatotoxicity. Store in sealed containers below 25°C away from moisture. Use appropriate PPE during handling to prevent inhalation risks.